Banding Ligation With Carvedilol Versus Carvedilol for the Prevention of First Bleeding

NCT01383044 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2020-11-20

No results posted yet for this study

Summary

Endoscopic variceal ligation (EVL) and carvedilol have been documented to be effective in prophylaxis of the first bleeding. The efficacy \& safety of combining EVL and carvedilol in prophylaxis of the first bleeding is still unknown. This study aims to investigate the value of combination therapy.

Conditions

  • Variceal Bleeding

Interventions

PROCEDURE

EVL + carvedilol

EVL is performed for 2-3 times carvedilol 6.25mg-12.5 mg per day

DRUG

carvedilol

carvedilol 6.25mg-12.5 mg per day

Sponsors & Collaborators

  • E-DA Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-08
Primary Completion
2015-07-30
Completion
2020-06-30

Countries

  • Taiwan

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01383044 on ClinicalTrials.gov